March 16, 2017 / 11:36 PM / 5 months ago

BRIEF-Stemline Therapeutics Q4 loss per share $0.56

March 16 (Reuters) - Stemline Therapeutics Inc

* Stemline therapeutics reports fourth quarter 2016 financial results

* Q4 loss per share $0.56

* Q4 earnings per share view $-0.55 -- Thomson Reuters I/B/E/S

* Qtrly grant revenue $299,401 versus $205,651 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below